Warshall was most recently COO at Pittston Co-Packers, where Reed’s said he “led the revitalisation of a large-scale beverage manufacturing facility and secured a multi-million-dollar revenue pipeline ...

J.S. Gornael has a BA in English with a Creative Writing Emphasis in Poetry and an MFA in Fiction. He has taken workshops in poetry, fiction, and non-fiction (though mostly the second). Half-cinephile ...

SPOILER ALERT: The following story contains plot details from “No One’s Normal. It Just Looks That Way from Across the Street,” the series finale of “DTF St. Louis,” now streaming on HBO Max. “DTF St.

Christina Radish is the Senior Entertainment Reporter at Collider. Having worked at Collider for over a decade (since 2009), her primary focus is on film and television interviews with talent both in ...

HOUSTON — A Houston man with a long criminal record is now accused of killing a young couple in one of the city’s most haunting cold cases, more than 35 years after their bodies were found in a remote ...

Forbes contributors publish independent expert analyses and insights. John Sviokla covers GenAI/AI's impact on commerce and society. This voice experience is generated by AI. Learn more. This voice ...

Shares of Recursion Pharmaceuticals (RXRX) spiked on Wednesday after the AI-driven drug developer significantly exceeded Street forecasts with its Q4 2025 financials, thanks primarily to a milestone ...

Legendary New Jersey comedian Floyd Vivino, known as “Uncle Floyd,” has died at 74. On Friday, his brother, musician Jerry Vivino, announced on social media that Floyd had passed away the previous day ...

Five years ago, video images from a Minneapolis street showing a police officer kneeling on the neck of George Floyd as his life slipped away ignited a social movement. Now, videos from another ...

Recursion Pharmaceuticals utilizes a proprietary operating system (OS) and an AI-powered algorithm that continuously runs virtual experiments, testing compounds against a library of human genes to ...

Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...